Canhelp Genomics is a leading healthcare company focused on molecular diagnostics & personalized medicine in the field of oncology. Dedicated to developing cutting-edge diagnostics, Canhelp Genomics improves patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. The company’s products uniquely combine genomic technology, clinical science and bioinformatics solution to generate insights that can help the accurate diagnosis of disease and help physicians match patients to more personalized treatment options. Since its founding in 2014, Canhelp Genomics has developed three genomic tests, which are improving the diagnosis of kidney cancer, lung cancer and metastatic tumors, and collectively target a $2 billion market opportunity. Canhelp Genomics is based in Joinstar Biomedical Valley, Hangzhou, China. For more information, please visit: www.canhelpdx.com.
Company’s Keywords:
cancer research, biomarker development, bioinformatics, tumor pathology
<6
<
<2014